The Pharma Spotlight

Dr Lorenz M. Mayr, Vice President, AstraZeneca, presented the current needs for protein production in an exciting keynote lecture at the ComplexINC annual meeting in Braunschweig, Germany. "Intelligent production technologies for proteins are urgently required to enhance the productivity of R&D activities in Pharma and Biotech" says Dr Mayr. ComplexINC, with its leading platform technologies and ambitious work programme, is excellently positioned to fill this vital gap. This is the second time Dr. Mayr has accepted the invitation to present a keynote at a meeting of the ComplexINC consortium. At the previous occasion in Munich in 2012, Dr. Mayr had presented the view from Novartis, Basel (Switzerland), where he had successfully served as Executive Director, prior to being recruited to Astra.